The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

62.60 0.91 −1.43%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. (COO) Free cash flow

Alert me on Free cash flow

The Cooper Companies, Inc.'s free cash flow for fiscal 2025 was $433.7M, up 50.5% from $288.1M in fiscal 2024. Over the twelve months to 31 July 2026 it was $678.0M. Over the past ten years it has ranged from $147.9M (fiscal 2015) to $524.2M (fiscal 2021); the current reading is higher than 64% of that period. The Cooper Companies, Inc. ranks 8th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $433.7M 50.54%
FY2024 $288.1M 34.00%
FY2023 $215.0M (52.26%)
FY2022 $450.4M (14.08%)
FY2021 $524.2M 197.50%
FY2020 $176.2M (58.16%)
FY2019 $421.1M (11.40%)
FY2018 $475.3M 1.91%
FY2017 $466.4M 30.64%
FY2016 $357.0M 141.38%

Quarterly newest first

Period Free cash flow Change
Jul 2026 $273.0M 183.20%
Apr 2026 $96.4M (39.26%)
Jan 2026 $158.7M 5.87%
Oct 2025 $149.9M (8.88%)
43 more quarters

Against its own ten years

Low $147.9M High $524.2M
Ten-year median $421.1M
Current reading's percentile 64

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on COO